United States Minimally Invasive Surgery Devices Market

United States Minimally Invasive Surgery Devices Market Overview:

The United States minimally invasive surgery devices market is projected to exhibit a growth rate (CAGR) of 6.50% during 2024-2032. The growing prevalence of chronic conditions like hypertension, diabetes, and heart disease among the masses, increasing advancements in technology to improve accuracy and efficacy, and rising patient demand for less invasive procedures are some of the factors impelling the market growth.

United States Minimally Invasive Surgery Devices Market Trends:

Growing Prevalence of Chronic Diseases

The rising prevalence of long-term illnesses like high blood pressure, diabetes, and heart disease among the masses is bolstering the market growth in the United States. Hypertension, in particular, notably increases the risk of complications during and after surgery, making minimally invasive surgery (MIS) a preferred option. These methods are less invasive, reducing surgical impact and lowering the chance of complications, which is particularly vital for patients with chronic conditions. The growing prevalence of chronic illnesses among individuals is catalyzing the demand for sophisticated MIS devices to manage these conditions. In 2023, the Food and Drug Administration (FDA) approved Medtronic's Symplicity Spyral™ renal denervation system for treating hypertension in the United States. This minimally invasive device employed radiofrequency energy to disrupt overactive renal nerves, striving to lower blood pressure in patients who do not react adequately to medication and lifestyle changes. The approval marked a noteworthy advancement in the management of high blood pressure, providing a novel therapeutic choice for patients.​

Advancements in Technology

Advancements, including robotics, artificial intelligence (AI), and improved imaging technology, are improving the accuracy and efficacy of these procedures, lowering the chance of complications. Surgeons can carry out intricate surgeries with more precision and flexibility using tools, such as robotic-assisted surgical systems and advanced endoscopic devices. This technological evolution is not only improving surgical outcomes but also expanding the scope of procedures that can be performed less invasively. Moreover, the incorporation of AI and machine learning (ML) in MIS tools is improving real-time decision-making and surgical planning, increasing the utilization of these tools in different fields like orthopedic, gynecological, and cardiovascular surgeries. In 2023, US Medical Innovations and the Jerome Canady Research Institute launched the Canady Robotic AI Surgical System, the first AI-powered robotic system using cold atmospheric plasma (CAP) technology. This system aimed to precisely target and eliminate microscopic tumor cells while preserving healthy tissue. It also featured advanced AI software, 3D navigational-guided surgical planning, and speech-activated robotic controls for various minimally invasive procedures.

Increasing Patient Demand for Less Invasive Procedures

Patient preferences are shifting towards less invasive surgical options because of the numerous benefits they offer, such as reduced pain, shorter hospital stays, quicker recovery times, and minimal scarring. Patients are becoming more knowledgeable about the benefits of MIS and are actively looking for healthcare providers who offer these choices. Moreover, the growing focus on patient-centered care by healthcare providers is resulting in a higher rate of adoption of MIS devices. Hospitals and surgical centers are investing in novel minimally invasive technologies in response to changing individual demands, aiming to enhance patient outcomes. In 2024, Intuitive revealed that the FDA approved 510(k) clearance for da Vinci 5, the company's latest robotic system, aimed at improving MIS. The da Vinci 5 has been enhanced with over 150 features, including better precision, an advanced 3D screen, and updated force-sensing technology intended to minimize tissue damage and enhance surgical accuracy.

United States Minimally Invasive Surgery Devices Market News:

• September 2023: Cleveland Clinic performed the first MI gastric sleeve surgery in the United States using an FDA-approved surgical robot with magnetic technology. This new robotic technology allowed surgeons to make fewer incisions, enhancing precision and reducing recovery times for patients.
• February 2024: Virtual Incision received FDA authorization for the MIRA Surgical System, the first miniaturized robotic-assisted surgery device, for colectomy procedures in adults. The authorization marked a significant milestone in advancing minimally invasive surgery.
   

United States Minimally Invasive Surgery Devices Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on products, and application.

Products Insights:

• Handheld Instruments
• Guiding Devices
• Electrosurgical Devices
• Endoscopic Devices
• Laparoscopic Devices
• Robotic Assisted Surgical Systems
• Ablation Devices
• Laser Based Devices
• Others
   

The report has provided a detailed breakup and analysis of the market based on the products. This includes handheld instruments, guiding devices. electrosurgical devices, endoscopic devices, laparoscopic devices, robotic assisted surgical systems, ablation devices, laser based devices, and others.

Application Insights:

• Aesthetic
• Cardiovascular
• Gastrointestinal
• Gynecological
• Orthopedic
• Urological
• Others
   

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes aesthetic, cardiovascular, gastrointestinal, gynecological, orthopedic, urological, and others.

Regional Insights:

• Northeast
• Midwest
• South
• West
   

The report has also provided a comprehensive analysis of all the major regional markets, which include Northeast, Midwest, South, and West.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

United States Minimally Invasive Surgery Devices Market Report Coverage:

Key Questions Answered in This Report:

• How has the United States minimally invasive surgery devices market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the United States minimally invasive surgery devices market?
• What is the breakup of the United States minimally invasive surgery devices market on the basis of products?
• What is the breakup of the United States minimally invasive surgery devices market on the basis of application?
• What are the various stages in the value chain of the United States minimally invasive surgery devices market? 
• What are the key driving factors and challenges in the United States minimally invasive surgery devices?
• What is the structure of the United States minimally invasive surgery devices market and who are the key players?
• What is the degree of competition in the United States minimally invasive surgery devices market? 

Key Benefits for Stakeholders:

• IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the United States minimally invasive surgery devices market from 2018-2032.
• The research report provides the latest information on the market drivers, challenges, and opportunities in the United States minimally invasive surgery devices market.
• Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the minimally invasive surgery devices industry and its attractiveness.
• Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.